Three-Dimensional Conformal Radiation Therapy for Esophageal Squamous Cell Carcinoma: Is Elective Nodal Irradiation Necessary?

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 2, 2010, Pages 446-451

  Zhao, Kuai le ^a   Ma, Jin bo ^b   Liu, Guang ^c   Wu, Kai liang ^a   Shi, Xue hui ^a   Jiang, Guo liang ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

^c Zhejiang Province Cancer Hospital   (China)

Author keywords

3 dimensional conformal radiotherapy; Esophageal carcinoma

Indexed keywords

3-DIMENSIONAL; CONFIDENCE INTERVAL; CONFORMAL RADIOTHERAPY; DISTANT METASTASIS; ESOPHAGEAL CARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; IN-FIELD RECURRENCE; LOCAL CONTROL; LOCAL FAILURE; LYMPH NODE; LYMPH NODE REGION; MEDIAN SURVIVAL; OVERALL SURVIVAL RATES; PLANNING TARGET VOLUMES; POSITIVE LYMPH NODES; PROSPECTIVE STUDY; REGIONAL FAILURES; REGIONAL NODAL RECURRENCE; SQUAMOUS CELL CARCINOMA; TARGET VOLUMES; THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY (3D-CRT); TREATMENT FAILURE;

BODY FLUIDS; FLUORESCENT SCREENS; IRRADIATION; PATHOLOGY; PATIENT MONITORING; RADIOTHERAPY; TOXICITY;

THREE DIMENSIONAL;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; DISTANT METASTASIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS DISEASE; FEMALE; HUMAN; LUNG DISEASE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; THREE DIMENSIONAL IMAGING; TRACHEA DISEASE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SURVIVAL RATE;

EID: 73649143524     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.078     Document Type: Article

References (19)

1. Zou X.N. Epidemiology. Chin J Cancer Prev Treat 13 (2006) 18-21
2. Holmes R.S., and Vaughan T.L. Epidemiology pathogenesis of esophageal cancer. Semin Oncol 31 (2007) 1-9
3. Crew K.D., and Neugut A.I. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 31 (2004) 450-464
4. Herskovic A., Martz K., Al-sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with esophageal cancer. N Engl J Med 326 (1992) 1593-1598
5. Minsky B.D., Neuberg D., Kelsen D.P., et al. Neoadjuvant chemotherapy plus concurrent chemotherapy and high dose radiation for squamous cell carcinoma of the esophagus: A preliminary analysis of the Phase II Intergroup Trial 0122. J Clin Oncol 14 (1996) 149-155
6. Shi X.H., Yao W.Q., and Lui T.F. Late course accelerated fractionation in radiotherapy of esophageal carcinoma. Radiother Oncol 51 (1999) 21-26
7. Wang Y., Shi X.H., He S.Q., et al. Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 54 (2002) 131-136
8. Zhao K.L., Gl J., Shi X.H., et al. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: A phase III randomized study. Int J Radiat Oncol Biol Phys 62 (2005) 1014-1020
9. Pollack A., Zagars G.K., Starkschall G., et al. Conventional vs. conformal radiotherapy for prostate cancer: Preliminary results of dosimetry acute toxicity. Int J Radiat Oncol Biol Phys 34 (1996) 555-564
10. Oh C.E., Antes K., Darby M., et al. Comparison of 2D conventional, 3D conformal, and intensity-modulated treatment planning techniques for patients with prostate cancer with regard to target-dose homogeneity and dose critical, uninvolved structures. Med Dosim 24 (1999) 255-263
11. Guzel Z., Bedford J.L., Childs P.J., et al. A comparison of conventional and conformal radiotherapy of the oesophagus: Work in progress. Br J Radiol 71 (1998) 1076-1082
12. Tai P., Van Dyk J., Yu E., et al. Radiation treatment for cervical esophagus: Patterns of practice study in Canada, 1996. Int J Radiat Oncol Biol Phys 47 (2000) 703-712
13. Tai P., Van Dyk J., Yu E., et al. Variability of target volume delineation in cervical esophageal cancer. Int J Radiat Oncol Biol Phys 42 (1998) 277-288
14. Mauer A.M., and Weichselbaum R.R. Multimodality therapy for carcinoma of the esophagus. In: Steels G.D., Phillips T.L., and Chabner B.A. (Eds). American Cancer Society atlas of clinical oncology: Cancer of the upper gastrointestinal tract (2002), BC Decker Inc, Chicago, IL
15. Miller C. Carcinoma of the esophagus and gastric cardiac. Br J Cancer 49 (1962) 507-522
16. Elkon D., Lee M.S., and Hendrickson F.R. Carcinoma of the esophagus: Sites of recurrence and palliative benefits after definitive radiotherapy. Int J Radiat Oncol Biol Phys 4 (1978) 615-620
17. Nomura1 T., Onda1 M., Miyashita1 M., et al. Wide-spread distribution of sentinel lymph nodes in esophageal cancer. J Nippon Med Sch 68 (2001) 393-396
18. Hosch S.B., Stoecklein N.H., Pichlmeier U., et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 19 (2001) 1970-1975
19. Wei X., Liu H., Tucker S.L., et al. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys 70 (2008) 707-714